The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)styryl)benzoic acid ID: ALA4551599
PubChem CID: 155555552
Max Phase: Preclinical
Molecular Formula: C22H18N4O3
Molecular Weight: 386.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc2[nH]cc(Cc3ccc(/C=C/c4ccccc4C(=O)O)cc3)c2c(=O)[nH]1
Standard InChI: InChI=1S/C22H18N4O3/c23-22-25-19-18(20(27)26-22)16(12-24-19)11-14-7-5-13(6-8-14)9-10-15-3-1-2-4-17(15)21(28)29/h1-10,12H,11H2,(H,28,29)(H4,23,24,25,26,27)/b10-9+
Standard InChI Key: QXLUOILIYGLPRE-MDZDMXLPSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
28.0115 -19.5796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0115 -20.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7168 -20.8012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7168 -19.1668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4221 -19.5796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4265 -20.3932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2017 -20.6405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6765 -19.9795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1945 -19.3240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7168 -18.3497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3044 -20.8064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4428 -18.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2412 -18.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7878 -18.9789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5856 -18.8051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8345 -18.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2796 -17.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4839 -17.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6327 -17.8504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8799 -17.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6780 -16.8962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2246 -17.5005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0221 -17.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2700 -16.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7142 -15.9412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9188 -16.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3643 -15.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6073 -14.7383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.5671 -15.6981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
2 11 1 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
27 28 1 0
27 29 2 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.41Molecular Weight (Monoisotopic): 386.1379AlogP: 3.29#Rotatable Bonds: 5Polar Surface Area: 124.86Molecular Species: ACIDHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.80CX Basic pKa: 2.27CX LogP: 3.62CX LogD: 0.49Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.39Np Likeness Score: 0.02
References 1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS.. (2019) Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors., 183 [PMID:31536894 ] [10.1016/j.ejmech.2019.111673 ]